Veeva Systems Current Ratio 2012-2025 | VEEV
Current and historical current ratio for Veeva Systems (VEEV) from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Veeva Systems current ratio for the three months ending April 30, 2025 was 4.61.
| Veeva Systems Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-04-30 | $6.71B | $1.46B | 4.61 |
| 2025-01-31 | $6.31B | $1.40B | 4.51 |
| 2024-10-31 | $5.45B | $0.86B | 6.36 |
| 2024-07-31 | $5.37B | $1.07B | 5.02 |
| 2024-04-30 | $5.25B | $1.22B | 4.29 |
| 2024-01-31 | $5.00B | $1.18B | 4.24 |
| 2023-10-31 | $4.34B | $0.77B | 5.64 |
| 2023-07-31 | $4.36B | $1.00B | 4.35 |
| 2023-04-30 | $4.19B | $1.01B | 4.16 |
| 2023-01-31 | $3.97B | $1.01B | 3.94 |
| 2022-10-31 | $3.39B | $0.69B | 4.91 |
| 2022-07-31 | $3.36B | $0.80B | 4.20 |
| 2022-04-30 | $3.28B | $0.88B | 3.73 |
| 2022-01-31 | $3.11B | $0.84B | 3.70 |
| 2021-10-31 | $2.66B | $0.54B | 4.95 |
| 2021-07-31 | $2.63B | $0.66B | 3.97 |
| 2021-04-30 | $2.50B | $0.71B | 3.52 |
| 2021-01-31 | $2.31B | $0.72B | 3.23 |
| 2020-10-31 | $1.85B | $0.42B | 4.44 |
| 2020-07-31 | $1.79B | $0.50B | 3.56 |
| 2020-04-30 | $1.68B | $0.55B | 3.04 |
| 2020-01-31 | $1.53B | $0.55B | 2.78 |
| 2019-10-31 | $1.66B | $0.31B | 5.40 |
| 2019-07-31 | $1.62B | $0.38B | 4.23 |
| 2019-04-30 | $1.54B | $0.41B | 3.73 |
| 2019-01-31 | $1.43B | $0.40B | 3.57 |
| 2018-10-31 | $1.18B | $0.24B | 5.00 |
| 2018-07-31 | $1.15B | $0.30B | 3.91 |
| 2018-04-30 | $1.10B | $0.33B | 3.38 |
| 2018-01-31 | $1.01B | $0.31B | 3.31 |
| 2017-10-31 | $0.85B | $0.21B | 3.95 |
| 2017-07-31 | $0.83B | $0.26B | 3.26 |
| 2017-04-30 | $0.79B | $0.27B | 2.93 |
| 2017-01-31 | $0.71B | $0.25B | 2.89 |
| 2016-10-31 | $0.59B | $0.17B | 3.52 |
| 2016-07-31 | $0.59B | $0.21B | 2.82 |
| 2016-04-30 | $0.55B | $0.21B | 2.65 |
| 2016-01-31 | $0.50B | $0.19B | 2.69 |
| 2015-10-31 | $0.43B | $0.14B | 3.13 |
| 2015-07-31 | $0.52B | $0.13B | 3.89 |
| 2015-04-30 | $0.51B | $0.14B | 3.72 |
| 2015-01-31 | $0.50B | $0.14B | 3.70 |
| 2014-10-31 | $0.45B | $0.11B | 4.17 |
| 2014-07-31 | $0.42B | $0.10B | 4.10 |
| 2014-04-30 | $0.42B | $0.10B | 4.14 |
| 2014-01-31 | $0.35B | $0.09B | 4.08 |
| 2013-10-31 | $0.33B | $0.07B | 4.68 |
| 2013-07-31 | $0.00B | 0.00 | |
| 2013-04-30 | $0.00B | 0.00 | |
| 2013-01-31 | $0.00B | 0.00 | |
| 2012-10-31 | $0.00B | 0.00 | |
| 2012-01-31 | $0.04B | $0.03B | 1.51 |
| 2011-01-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $46.883B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hims & Hers Health (HIMS) | United States | $14.668B | 152.40 |
| Doximity (DOCS) | United States | $11.054B | 51.17 |
| Tempus AI (TEM) | United States | $10.008B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.472B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.870B | 60.47 |
| Hinge Health (HNGE) | United States | $3.513B | 0.00 |
| Privia Health (PRVA) | United States | $2.388B | 163.25 |
| 10x Genomics (TXG) | United States | $1.713B | 0.00 |
| Phreesia (PHR) | United States | $1.608B | 0.00 |
| Enovis (ENOV) | United States | $1.544B | 8.61 |
| Azenta (AZTA) | United States | $1.530B | 71.11 |
| Schrodinger (SDGR) | United States | $1.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.476B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 24.55 |
| Evolent Health (EVH) | United States | $1.162B | 99.00 |
| Claritev (CTEV) | United States | $0.636B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.532B | 0.00 |
| Standard BioTools (LAB) | United States | $0.524B | 0.00 |
| Veradigm (MDRX) | United States | $0.507B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.448B | 0.00 |
| Talkspace (TALK) | United States | $0.418B | 125.00 |
| TruBridge (TBRG) | United States | $0.315B | 698.67 |
| Outset Medical (OM) | United States | $0.300B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
| CapsoVision (CV) | United States | $0.190B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.175B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.077B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |